Conditions: Open-angle Glaucoma (OAG) Ocular Hypertension
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 60
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the safety and efficacy of three concentrations of travoprost ophthalmic solution (Groups A, B and C) administered eight times daily.

Detailed description:

Arms:
arm 1: TRAVATAN 0.004% once daily arm 2: Travoprost Vehicle arm 3: Travoprost Group A arm 4: Travoprost Group B arm 5: Travoprost Group C

Interventions: intervention 1: Travoprost 0.004% intervention 2: Travoprost Vehicle intervention 3: Travoprost (Groups A, B and C)
Intervention descriptions: intervention 1: 1 drop in each eye once daily for five days, and 1 drop vehicle in each eye 7 times daily for 5 days intervention 2: 1 drop in each eye 8 times daily for 5 days intervention 3: 1 drop in each eye 8 times daily for 5 days

Protocol document: